Peptipedia
BioregulatorNot FDA ApprovedClinical Trials

Thymalin

Also known as Thymic Factor, Thymus Extract

A thymic peptide complex utilized in Russia for immune enhancement and longevity support, developed through Professor Khavinson's bioregulator peptide research.

Approved in Russia - Not FDA approved
CompareFind Vendors

Regulatory Pathway

Preclinical
Phase I
Phase II
Phase III
Phase IV
Approved

Dosing Protocol

Typical Dose

10-20 mg daily for 5-10 days

Frequency

Daily during cycles

Duration

10-day cycles, 1-2 times yearly

Community-reported dosing. Individual results vary. Not a medical recommendation.
Typical community protocol: 10-20 mg daily for 5-10 days via Intramuscular injection, Daily during cycles. Dose range: 10-20 mg daily. Duration: 10-day cycles, 1-2 times yearly.

Timing & Administration

Administer via Intramuscular injection. Frequency: Daily during cycles.

Mechanism of Action

Contains peptides that regulate thymic function and T-cell development. Restores age-related immune decline, normalizes thymic hormone levels, and has demonstrated effects on longevity markers.

Research Summary

Evidence level: clinical trials. Clinical status: Approved in Russia - Not FDA approved.

Side Effects & Safety

Important Warnings

  • Excellent safety profile noted in Russian studies
Allergic reactions (rare)
injection site reactions
flu-like symptoms (rare)

References

No references available.

Related Peptides

Browse all →
EpithalonBioregulator

A tetrapeptide studied for its effects on telomerase activation and potential anti-aging properties.

View profile
Thymosin Alpha-1Immune

A naturally occurring thymic peptide that enhances immune function.

View profile
PinealonBioregulator

A synthetic tripeptide bioregulator targeting brain tissue, designed to support cognitive function and neuroprotection as part of Khavinson's peptide research.

View profile